Vagus Nerve Stimulation Clinical Trial
Official title:
Transcutaneous Auricular Vagus Nerve Stimulation: Comparison of Effectiveness of In-ear and Behınd-ear Stimulation
Verified date | March 2024 |
Source | Bahçesehir University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The use of vagus nerve stimulation (VSS), one of the examples of neuromodulation therapies, continues to increase in the medical field. Basically, invasive (iVSS) and transcutaneous VSS (tVSS) can be performed. tVSS is more preferred because of its advantages such as easy application, not requiring surgical procedure and having fewer side effects. VSS has long been an approved treatment modality in the treatment of epilepsy and refractory depression. tVSS can be administered from the auricular-auricular or posterior ear region. The vagus nerve (VS) belongs to the parasympathetic branch of the autonomic nervous system and has an effect on vital functions. There are also studies in the literature showing that VS stimulation reduces inflammation. In addition to this effect, the vagus nerve may also show analgesic activity through pain-related pathways. Due to its anti-inflammatory and analgesic effects, VSS has become a new treatment method in diseases in which various inflammatory processes are shown in the etiology such as inflammatory bowel diseases, musculoskeletal system diseases and central nervous system diseases.
Status | Completed |
Enrollment | 76 |
Est. completion date | December 30, 2023 |
Est. primary completion date | December 1, 2023 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Male |
Age group | 18 Years to 45 Years |
Eligibility | Inclusion Criteria: - To be 18 years of age or older, - Not having any acute or chronic health problems, - No previous transcutaneous vagus nerve stimulation application. Exclusion Criteria: - Using drugs, alcohol or smoking - Being in the post menopausal phase - Pregnancy history - Known history of acute or chronic illness - Having received any medication affecting the autonomic nervous system |
Country | Name | City | State |
---|---|---|---|
Turkey | Igdir University | Igdir | Central |
Lead Sponsor | Collaborator |
---|---|
Bahçesehir University |
Turkey,
Carandina A, Rodrigues GD, Di Francesco P, Filtz A, Bellocchi C, Furlan L, Carugo S, Montano N, Tobaldini E. Effects of transcutaneous auricular vagus nerve stimulation on cardiovascular autonomic control in health and disease. Auton Neurosci. 2021 Dec;236:102893. doi: 10.1016/j.autneu.2021.102893. Epub 2021 Oct 9. — View Citation
Clancy JA, Mary DA, Witte KK, Greenwood JP, Deuchars SA, Deuchars J. Non-invasive vagus nerve stimulation in healthy humans reduces sympathetic nerve activity. Brain Stimul. 2014 Nov-Dec;7(6):871-7. doi: 10.1016/j.brs.2014.07.031. Epub 2014 Jul 16. — View Citation
Peng X, Baker-Vogel B, Sarhan M, Short EB, Zhu W, Liu H, Kautz S, Badran BW. Left or right ear? A neuroimaging study using combined taVNS/fMRI to understand the interaction between ear stimulation target and lesion location in chronic stroke. Brain Stimul. 2023 Jul-Aug;16(4):1144-1153. doi: 10.1016/j.brs.2023.07.050. Epub 2023 Jul 28. — View Citation
Szeles JC, Kampusch S, Thurk F, Clodi C, Thomas N, Fichtenbauer S, Schwanzer C, Schwarzenberger S, Neumayer C, Kaniusas E. Bursted auricular vagus nerve stimulation alters heart rate variability in healthy subjects. Physiol Meas. 2021 Oct 29;42(10). doi: 10.1088/1361-6579/ac24e6. — View Citation
Trevizol AP, Shiozawa P, Taiar I, Soares A, Gomes JS, Barros MD, Liquidato BM, Cordeiro Q. Transcutaneous Vagus Nerve Stimulation (taVNS) for Major Depressive Disorder: An Open Label Proof-of-Concept Trial. Brain Stimul. 2016 May-Jun;9(3):453-454. doi: 10.1016/j.brs.2016.02.001. Epub 2016 Feb 10. No abstract available. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Heart Rate Variability | The effectiveness of vagus nerve stimulation, its effect on autonomic nervous system activity was evaluated using heart rate variability. Polar H7 device was used for this. The heart rate was recorded non-invasively over the chest for 5 minutes and the beat-to-beat (R-R) variability was measured with Kubios software. | Baseline and immediately after the intervention |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05343039 -
Technology Enhanced Adolescent Mental Health (TEAM)
|
N/A | |
Recruiting |
NCT05992259 -
Auricular Vagus Stimulation and STEMI
|
N/A | |
Completed |
NCT04643808 -
taVNS Paired With Bottle Feeding in Infants Failing Oral Feeds
|
Early Phase 1 | |
Not yet recruiting |
NCT05417711 -
Efficacy of Transcutaneous Vagus Nerve Stimulation Paired With Tailor-Made Notched Music Therapy Versus Tailor-made Notched Music Training for Chronic Subjective Tinnitus
|
N/A | |
Not yet recruiting |
NCT06121947 -
Safety and Efficacy Study of Implantable Neuromodulation for Poststroke Hemiplegia
|
N/A | |
Completed |
NCT04150627 -
Effect of Breathing Maneuvers on Peripheral Glucose Metabolism
|
N/A | |
Recruiting |
NCT06421090 -
Transauricular Vagal Nerve Stimulation Improves Postoperative Delirium in Elderly Patients
|
N/A | |
Recruiting |
NCT06421077 -
Transauricular Vagus Nerve Stimulation Improves Postoperative Delirium in Elderly Patients
|
N/A | |
Not yet recruiting |
NCT06381089 -
Effect Of Robotic Rehabilitation And Vagus Nerve Stimulation In Ischemia Stroke Patients
|
N/A | |
Not yet recruiting |
NCT06421051 -
Transauricular Vagus Nerve Stimulation Improves Postoperative Sleep Disorders in Elderly Patients.
|
N/A | |
Terminated |
NCT04256837 -
Effect of Transcutaneous Electrical Auricular Stimulation of the Vagus Nerve in Kidney Transplant Recipients
|
N/A | |
Completed |
NCT05218109 -
Stress and Sleep Study
|
N/A | |
Recruiting |
NCT05680337 -
Auricular Vagus Stimulation and Heart Rate Variability
|
N/A | |
Completed |
NCT05088135 -
The Effect of Auricular Vagus Nerve Stimulation on EEG and EMG Measurement in Healthy Persons
|
N/A | |
Not yet recruiting |
NCT05866471 -
Pairing Psilocybin With Transcutaneous Auricular Vagus Nerve Stimulation
|
Phase 1 | |
Active, not recruiting |
NCT04632069 -
NAC +taVNS in IDM Who Are Poor Oral Feeders
|
Early Phase 1 | |
Active, not recruiting |
NCT05230628 -
Auricular Vagus Stimulation in Obesity
|
N/A | |
Completed |
NCT06086236 -
Vagus Nerve Stimulation Effects on Autonomic Nervous System Activity
|
N/A | |
Completed |
NCT04341649 -
Multi-device Testing for Autonomic Nervous System Stimulation
|
N/A |